Stay updated on Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.

Latest updates to the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew revision entry v3.4.2 was added to the history, and the prior revision v3.4.1 along with a government funding notice banner was removed, reflecting routine maintenance rather than substantive study changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA government funding lapse notice was added and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedThe update adds a glossary toggle and maintains color-coded change highlights (green for additions, red for deletions) while removing the 'No FEAR Act data' line and updating the revision label from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check42 days agoChange DetectedThe revision history shows a new entry for v3.3.4 and removal of v3.3.3, which is a metadata/version-control update rather than a change to study data or core page content.SummaryDifference0.1%

- Check63 days agoChange DetectedThe history page adds a new revision entry (v3.3.3) and removes the HHS Vulnerability Disclosure link along with the earlier revision (v3.3.2); these are minor administrative updates to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange Detected- Added Contacts/Locations and updated Study Status in the record history to reflect updated site information and current recruitment status. - There is a deletion recorded on 2025-09-22 in the history.SummaryDifference0.3%

Stay in the know with updates to Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.